跳至主要内容
临床试验/NCT04398069
NCT04398069Unknown不适用

Hemodynamic Optimisation Guided With Transcranial Doppler in Septic Shock

Mongi Slim Hospital1 个研究点 分布在 1 个国家目标入组 24 人开始时间: 2020年1月2日最近更新:
适应症
干预措施

试验速览

阶段
不适用
入组人数
24
试验地点
1
主要终点
mortality at day 28

研究概览

简要总结

Randomized, controlled, prospective trial, including ICU patients with Sepsis or septic Shock, at the early phase.

patients will be randomized in 2 groups regarding the hemodynamic management and catecholamin doses:

  • Group 1: standard hemodynamic goals and catecholamin infusion to achieve: mean arterial pressure > or equal to 65 mmHg and diastolic arterial pressure > ou equal to 50 mmHg within the first 60 minutes.
  • Group 2: personalized hemodynamic goals and catecholamin infusion until normal transcranial doppler: IP<1,2.

详细描述

Randomized, controlled, prospective trial, including ICU patients with Sepsis or septic Shock, at the early phase.

patients will be randomized in 2 groups regarding the hemodynamic management and catecholamin doses:

  • Group 1: standard hemodynamic goals and cathecolamin infusion to achieve: mean arterial pressure > or equal to 65 mmHg and diastolic arterial pressure > ou equal to 50 mmHg within the first 60 minutes.
  • Group 2: personalized hemodynamic goals and cathecolamin infusion until normal transcranial doppler: IP<1,2.

For the 2 groups, standard management including: microbiological sampling, early broad spectrum anti infective therapy, fluid management and decreasing of blood lactate levels, will be aimed within the first 60 minutes.

For the Group 2 patients: personalized hemodynamic management will be maintained during 72 hours.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •All ICU patients presenting septic shock
  • •No criteria of traumatic or vascular brain injury

排除标准

  • •Patients with refractory septick shock
  • •rapid fatal evolution: before 72 hours
  • •No individualisation of the MCA ultrasonographic window

研究组 & 干预措施

Standard Group

No Intervention

standard hemodynamic goals and catecholamin infusion to achieve: mean arterial pressure > or equal to 65 mmHg and diastolic arterial pressure > ou equal to 50 mmHg within the first 60 minutes.

personalized hemodynamic goals Group

Experimental

Personalized hemodynamic goals and catecholamin infusion to achieve normal cerebral perfusion assessed by transcranial doppler: PI < 1,2.

干预措施: hemodynamic optimisation aiming to achieve normal cerebral perfusion (Procedure)

结局指标

主要结局

mortality at day 28

时间窗: 28 days after ICU admission

Mortality at day 28

次要结局

  • Incidence of sepsis associated encephalopathy(28 days after ICU admission)
  • Incidence of sepsis related organ failures(28 days after ICU admission)
  • Length of ICU stay(30 days after end of randomization)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Mhamed Sami Mebazaa

Professor head of the anesthesia and intensive care department

Mongi Slim Hospital

研究点 (1)

Loading locations...

相似试验